No Prescription |
 |
 | ||
|
Centrum Multivitamin |
|
| ||
No Prescription » Prescription Drugs 4 » Centrum Multivitamin Centrum« is a complete multivitamin that helps you stay healthy with specially-balanced combinations of nutrients. - Supports immune system defenses with a balance of essential antioxidants like vitamin C and selenium* - Maintains strong bones with the balanced combination of vitamin D and calcium* - Supports proper muscle and nerve function with magnesium and vitamin D* Each Tablet Contains % Daily Value Vitamin A 3500 IU (29% as Beta-Carotene) 70% Vitamin C 90 mg 150% Vitamin D 400 IU 100% Vitamin E 30 IU 100% Vitamin K 25 mcg 31% Thiamin 1.5 mg 100% Riboflavin 1.7 mg 100% Niacin 20 mg 100% Vitamin B6 2 mg 100% Folic Acid 500 mcg 125% Vitamin B12 6 mcg 100% Biotin 30 mcg 10% Pantothenic Acid 10 mg 100% Calcium 200 mg 20% Iron 18 mg 100% Phosphorus 109 mg 11% Iodine 150 mcg 100% Magnesium 100 mg 25% Zinc 11 mg 73% Selenium 55 mcg 79% Copper 0.9 mg 45% Manganese 2.3 mg 115% Chromium 35 mcg 29% Molybdenum 45 mcg 60% Chloride 72 mg 2% Potassium 80 mg 2% Buy Centrum Multivitamin and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Centrum Multivitamin: Product Type: Prescription Drugs 4 Centrum (Multivitamin) Product Origin: NewZealand Centrum (Multivitamin) Multivitamin 3500IU/90mg/400IU 60 Tablets 120 Tablets Multivitamin Centrum
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
